Health & Environmental Research Online (HERO)


Print Feedback Export to File
7414535 
Journal Article 
Triptorelin in the Treatment of Prostate Cancer 
Heyns, CF; , 
2005 
1 
American Journal of Cancer
ISSN: 1175-6357 
INT INST ANTICANCER RESEARCH 
ATHENS 
169-183 
15816630 
WOS:000228138000029 
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.